Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ýíäîêðèíîëîãèÿ > Ôîðóì äëÿ îáùåíèÿ âðà÷åé ýíäîêðèíîëîãîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 13.10.2015, 20:32
ChakaKhan ChakaKhan âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 11.10.2009
Ãîðîä: Kiev
Ñîîáùåíèé: 25
Ñêàçàë(à) ñïàñèáî: 6
ChakaKhan *
äèô äèàãíîñòèêà ãèïåðïàðàòèðåîçà

óâ.êîëëåãè ïîìîãèòå ñîâåòîì .Ïàöèåíòêà 54 ãîäà îáðàòèëàñü ñ æàëîáàìè íà âïåðâûå âîçíèêøåå ïîâûøåíèå ÀÄ äî 160\80,ñîïðîâîæäàþùååñÿ ÷óâñòâîì ñòðàõà.Ñóõîñòü âî ðòó æàæäó,÷àñòîå ìî÷åèñïóñêàíèå. Äåïðåññèâíîå ñîñòîÿíèå.  àíàìíåçå 20 ëåò íàçàä ëå÷èëàñü ïî ïîâîäó ëèìôîãðàíóëîìàòîçà ñåé÷àñ ñòîéêàÿ ðåìèññèÿ. Ìåíîïàóçà 8 ëåò.Îáñëåäîâàííà ÒÒÃ,ìåòàíåôðèíû ìî÷è â íîðìå. Ìî÷åñîëåâîé äèàòåç.Äàâëåíèå íîðìàëèçîâàëîñü íà ôîíå íåáèëåòà
Êàëüöèé îáùèé 2.72(äî 2.65)
îáùèé áåëîê 78.0(äî 83),
êàëüöèé èîíèçèðîâàííûé 1.36(äî 1.32)
â äðóãîé ëàáîðàòîðèè ïàðàòãîðìîí 116(äî 65)
êàëüöèé îáùèé 2.659 (Äî 2.5)êàëüöèé èîíèçèðîâàííûé 1.43(äî 1.32)
ôîñôîð 0.99 (0.78-1.65)
êàëüöèé â ñóòî÷íîé ìî÷å 6.7(2.5-7.5)
25-ãèäðîêñèâèòàìèí Ä 38.7[]ìåíüøå 50 äåôèöèò), ìàãíèé êðîâè,êðåàòèíèí êðîâè â íîðìå.
ÓÇÈ òðèæäû â ðàçíûõ ñïåöèàëèçèðîâàííûõ öåíòðàõ---äàííûõ çà àäåíîìó ïàðàùèòîâèäíîé æåëåçû íå âûÿâëåííî,êîëëîèäíûå óçëû ùèòîâèäíîé æåëåçû äî 4 ìì
Ñöèíòèãðàôèÿ ñ 99 ÒÑ Ì²Á² â ðàííþþ ôàçó â ïðîåêöèè ù.æ îïðåäåëÿåòñÿ íåðàâíîìåðíîå íåèíòåíñèâíîå íàêîïëåíèå ðàäèîôàðìïðåïàðàòà áîëåå âûðàæåííîå ñïðàâà ,áåç çàäåðæêè âûâåäåíèÿ â îòñðî÷åííóþ ôàçó-- óáåäèòåëüíûõ äàííûõ çà àäåíîìó ïðàùèòîâèäíîé æåëåçû íå âûÿâëåííî .
Äåíñèòîìåòðèÿ Ò êðèòåðèé áåäðî -1,ïîçâîíî÷íèê â íîðìå.
Õèðóðãè ïðåäëàãàþò ðåâèçèþ,óäàëåíèå ïàðàùèòîâèäíîé æåëåçû,ìíåíèÿ ýíäîêðèíîëîãîâ ðàçäåëèëèñü îäíè çà ÌÐÒ øåè è ïîèñê àäåíîìû,äðóãèå çà ïðîáíîå ëå÷åíèå íåáîëüøèìè äîçàìè âèòàìèíà Ä. Ïåðâè÷íûé èëè âòîðè÷íûé ãèïåðïàðàòèðåîç?ïî àíàëèçàì áîëüøå ïåðâè÷íûé íî àäåíîìû íèãäå íå âèäíî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 14.10.2015, 01:23
Àâàòàð äëÿ SergeyPlyasunov
SergeyPlyasunov SergeyPlyasunov âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 13.01.2002
Ãîðîä: Ñàìàðà, ÐÔ
Ñîîáùåíèé: 1,733
Ñêàçàë(à) ñïàñèáî: 1
Ïîáëàãîäàðèëè 159 ðàç(à) çà 154 ñîîáùåíèé
SergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSergeyPlyasunov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñöèíòèãðàôèÿ ñ 99 ÒÑ Ì²Á² â ðàííþþ ôàçó â ïðîåêöèè ù.æ îïðåäåëÿåòñÿ íåðàâíîìåðíîå íåèíòåíñèâíîå íàêîïëåíèå ðàäèîôàðìïðåïàðàòà áîëåå âûðàæåííîå ñïðàâà ,áåç çàäåðæêè âûâåäåíèÿ â îòñðî÷åííóþ ôàçó-- óáåäèòåëüíûõ äàííûõ çà àäåíîìó ïðàùèòîâèäíîé æåëåçû íå âûÿâëåííî .
Èíîãäà èç ïàðàòèðîìû ñêîðîñòü âûìûâàíèÿ òàêàÿ æå, êàê è èç ÙÆ. Ïîýòîìó ÿ âñåãäà äåëàþ âòîðûì ýòàïîì (îáû÷íî â ýòîò æå äåíü) ñöèíòèãðàôèþ ñ ïåðòåõíåòàòîì.
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 14.10.2015, 08:50
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàâåðíîå, áûëî áû ðàçóìíî èññëåäîâàòü ôðàêöèîíèðîâàííóþ ýêñêðåöèþ êàëüöèÿ.

Öèòàòà:
In the initial investigation of identifying the cause of abnormal calcium metabolism, a 24-hour urine collection for calcium, urine volume, and creatinine should be performed along with blood testing. The 2 methods most commonly used by clinicians to determine abnormality in renal excretion of calcium are measurement of 24-hour urine CE or calculation of the 24-hour urine calcium/creatinine excretion ratio (CR).[7] Recent research, however, seems to indicate that these tests may not adequately identify hyperparathyroid patients. Instead, the calculation of the calcium/creatinine clearance ratio (CCCR), also known as the fractional excretion of calcium (FEca), may be a better method by which to identify the cause of abnormal calcium determinations of plasma calcium and creatinine along with the 24-hour renal excretions of calcium and creatinine and applying the following formula: (24-hour U-calcium/P-total calcium)/(24-hour U-creatinine/P-creatinine).[8,9]
- Urine Calcium: Laboratory Measurement and Clinical Utility - Kevin F. Foley, PhD, DABCC; Lorenzo Boccuzzi, DO - Lab Med. 2010;41(11):683-686 ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]). Óðîâåíü áîëåå 1% ïîäòâåðæäàåò äèàãíîç ïåðâè÷íîãî ÃÏÒ.

Èëè áîëåå óäîáîâàðèìî:
[Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì]

Äðóãîé âîïðîñ - ñîîòâåòñâóåò ëè äàííàÿ ïàöèåíòêà êðèòåðèÿì îïåðàòèâíîãî âìåøàòàòåëüñòâà ïðè ïåðâè÷íîì ÃÏÒ (ñì., íàïðèìåð, òàáë. 4 â A Practical Approach to Hypercalcemia AAFP - [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]). À äåôèöèò âèòàìèíà D - ïî÷åìó íå ñêîððåêòèðîâàòü?
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 15.10.2015, 13:27
ChakaKhan ChakaKhan âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 11.10.2009
Ãîðîä: Kiev
Ñîîáùåíèé: 25
Ñêàçàë(à) ñïàñèáî: 6
ChakaKhan *
Äëÿ êîððåêöèè âèòàìèíà Ä íàçíà÷èëà àêâàäåòðèì 2000 ÌÅ(4 êàïëè) ñ êîíòðîëåì êàëüöèÿ èîíèçèðîâàííîãî ÷åðåç 2 íåäåëè.Îäíàêî ïðè êîíñóëüòàöèè â íàøåì ÍÈÈ Åíäîêðèíîëîãèè â êàòåãîðè÷íîé ôîðìå ñêàçàëè ÷òî íèççÿÿÿ! áóäåò ãèïåðêàëüöèåìè÷åñêèé êðèç!! Ïîñåìó âîïðîëñ ñ êîððåêöèåé äåôèöèòà Ä ïîâèñ â âîçäóõå. Ïî êðèòåðèÿì ïàöèåíòêà íå ïîäëåæèò îïåðàòèâíîìó ëå÷åíèþ . Âîçìîæíî ëè íàçíà÷èòü Áèôîñôîíàòû ñ âèòàìèíîì Ä íå îïàñàÿñü ýòîãî êðèçà?
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 15.10.2015, 13:33
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ãîëîâó íà ïëàõó íå ïîëîæó - ìíå íàäî ÷òî-òî ïî÷èòàòü.
Íî åñëè ïðåäñòàâèòü ñèòóàöèþ, â êîòîðîé "ìÿãêèé" ïåðâè÷íûé ÃÏÒ ðàçâèëñÿ ó ëèöà, íå èìåþùåãî äåôèöèòà âèòàìèíà D - óâåëè÷èì ëè ìû ðèñê ãèïåðêàëüöèåìè÷åñêîãî êðèçà, åñëè ïðèáëèçèìñÿ ê òàêîìó ñëó÷àþ?

Äà è âåðõíèé ðåôåðåíñ êàëüöèÿ èîíèçèðîâàííîãî, ÅÌÍÈÏ, ÷àùå îïðåäåëÿåòñÿ â 1,35-1,4 ììîëü/ë (îïàñíàÿ ãèïåðêàëüöåìèÿ - áîëåå 1,75 ììîëü/ë), òàê ÷òî ó îïèñûâàåìîé ïàöèåíòêè ïîâûøåíèå (åñëè åñòü) - óæ î÷åíü ïîãðàíè÷íîå.

Öèòàòà:
Ñîîáùåíèå îò ChakaKhan Ïîñìîòðåòü ñîîáùåíèå
Ïî êðèòåðèÿì ïàöèåíòêà íå ïîäëåæèò îïåðàòèâíîìó ëå÷åíèþ .
- ýòî - ê âîïðîñó î ðåâèçèè.

Ïîäîæä¸ì åùå ìíåíèÿ óìíûõ êîëëåã.

A propos: âñå ìåäèêàìåíòîçíûå ïðè÷èíû ãèïåðêàëüöåìèè (âêëþ÷àÿ ëèòèé) - èñêëþ÷åíû?
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 15.10.2015, 14:21
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,385
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,656 ðàç(à) çà 32,730 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âòîðè÷íîãî ãèïåðïàðàòèðîçà íåò - ýòî åäèíñòâåííàÿ òî÷íàÿ âåùü. Íåò è ñåìåéíîé ãèïîêàëüöèóðè÷åñêîé ãèïåðêàëüöèåìèè- òîæå ÿñíî .
Åñòü ìÿãêèé ãèïåðïàðàòèðîç è îñîáûõ âîçðàæåíèé ïðîòèâ íàçíà÷åíèÿ âèò D íåò - õîòÿ 38 íå òàêîé óæ äåôèöèò è ñìûñëà òîæå íåò Êîñòè è ïî÷êè ? Ïèòàíèå ? Ïàðàòãîðìîí - ïîäîáíûé ïåïòèä?

Êîììåíòàðèè ê ñîîáùåíèþ:
Samitin îäîáðèë(à):
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 15.10.2015, 20:58
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ãàëèíà Àôàíàñüåâíà, ñïàñèáî!
ß ñ ãèïåðêàëüöåìèåé íà ôîíå ëèìôîïðîëèôåðàòèâíûõ è ãðàíóëåìàòîçíûõ çàáîëåâàíèé "æèâü¸ì" íå ñòàëêèâàëñÿ è äóìàë, ÷òî îíà íå-ÏÒÃ-îïîñðåäîâàííàÿ è ÏÒà íå äîëæåí áûòü ïîâûøåí; ìîæåò ëè ÏÒÃ-ïîäîáíûé ïåïòèä äàâàòü èíòåðôåðåíöèþ?

Ïðî äåôèöèò D - ïîíèìàþ, ÷òî íåâåëèê, íî ÷èòàë, ÷òî óðîâíè ìåíåå 50 óòðà÷èâàþò ñóïðåññèâíîå âëèÿíèå íà ÏÒÃ, à ïîòîìó ÷èñòî ìåõàíèñòè÷åñêè ïðåäïî÷åë áû äåôèöèò ëèêâèäèðîâàòü.
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 16.10.2015, 09:32
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ê âîïðîñó î êîððåêöèè äåôèöèòà âèòàìèíà D ïðè ïåðâè÷íîì ãèïåðïàðàòèðåîçå:

Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D (European Journal of Endocrinology (2009) 161 189–193) - [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ].

Öèòàòà:
Objective: To determine whether vitamin D repletion of patients with primary hyperparathyroidism
...
Conclusion: These data fail to demonstrate any adverse effects of vitamin D repletion in PHPT.
Vitamin D deficiency and primary hyperparathyroidism (J Bone Miner Res. 2007 Dec;22 Suppl 2:V100-4. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ])
Abstract

Öèòàòà:
... an association between vitamin D deficiency and severity of primary hyperparathyroidism has been proposed. Data support an association on two distinct levels. First, regardless of the clinical severity of primary hyperparathyroidism, the disease seems to be more severe in those with concomitant vitamin D deficiency. Second, vitamin D deficiency and insufficiency seem to be more prevalent in patients with primary hyperparathyroidism than in geographically matched populations. The association between vitamin D deficiency and primary hyperparathyroidism has clear implications. Co-existing vitamin D deficiency may cause the serum calcium level to fall into the normal range, which can lead to diagnostic uncertainty. With regard to management, preliminary data on vitamin D repletion in patients with mild primary hyperparathyroidism suggest that, in some cases, correction of vitamin D deficiency may be accomplished without worsening the underlying hypercalcemia. Vitamin D-deficient patients undergoing parathyroidectomy are also at increased risk of postoperative hypocalcemia and "hungry bone syndrome," which underscores the importance of preoperative assessment of vitamin D status in all patients with primary hyperparathyroidism.
Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency (J Clin Endocrinol Metab. 2005 Apr;90(4):2122-6. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ])

Öèòàòà:
...Here we report the effects of vitamin D repletion on biochemical outcomes over 1 yr in a group of 21 patients with mild PHPT [serum calcium <12 mg/dl (3 mmol/liter)] and coexistent vitamin D insufficiency [serum 25 hydroxyvitamin D [25(OH)D] <20 microg/liter (50 nmol/liter)]. In response to vitamin D repletion to a serum 25(OH)D level greater than 20 microg/liter (50 nmol/liter), mean levels of serum calcium and phosphate did not change, and serum calcium did not exceed 12 mg/dl (3 mmol/liter) in any patient. Levels of intact PTH fell by 24% at 6 months (P < 0.01) and 26% at 12 months (P < 0.01). There was an inverse relationship between the change in serum 25(OH)D and that in intact PTH (r = -0.43, P = 0.056). At 12 months, total serum alkaline phosphatase was significantly lower, and urine N-telopeptides tended to be lower than baseline values (P = 0.02 and 0.13, respectively). In two patients, 24-h urinary calcium excretion rose to exceed 400 mg/d, but the group mean 24-h urinary calcium excretion did not change. These preliminary data suggest that vitamin D repletion in patients with PHPT does not exacerbate hypercalcemia and may decrease levels of PTH and bone turnover. Some patients with PHPT may experience an increase in urinary calcium excretion after vitamin D repletion.
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 16.10.2015, 19:16
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,385
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,656 ðàç(à) çà 32,730 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïðè ãðàíóëîìàòîçíûõ äá âûñîêèé 25 ( îí) D , íî ìû íå çíàåì, êàê äàâíî ãèïåðêàëüöèåìèÿ - îïóõîëåâàÿ îáû÷íî âûÿâëÿåòñÿ òîãäà, êîãäà îïóõîëü óæå íàõîäèáåëüíà, à âîò ñàðêîèäîç ìá ìèíèìàëüíî âèäèì
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 23.10.2015, 10:40
ChakaKhan ChakaKhan âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 11.10.2009
Ãîðîä: Kiev
Ñîîáùåíèé: 25
Ñêàçàë(à) ñïàñèáî: 6
ChakaKhan *
Ñïàñèáî,íà÷àëè ïðèíèìàòü âèòàìèí Ä
Ïàðàòãîðìîíïîäîáíûé ïåïòèä ó íàñ íå äåëàþò
Êîñòè: ïîçâîíî÷íèê ò êðèòåðèé, -0.5,áåäðî -1,ïåðåëîìîâ íå áûëî. Äåô àðòðîç êîëåíè è ãîëåíîñòîïû.
Ïî÷êè;ÓÇÈ,ÎÀÌ,ìî÷åâèíà, êðåàòèíèí â íîðìå
Æåëóäîê: ýððîçèâíûé ãàñòðèò ( ÔÃÄÑ)
Ïðîâåäåíî ÌÐÒøåè ñ êîíòðàñòîì(òîìîâèñò) â ïðîåêöèè í/ïîëþñà ùèòîâèäíîé æåëåçû îáðàçîâàíèå 7 ìì ñëàáîãèïåðèíòåíñèâíî íàêàïëèâàåò êîíòðàñò ïî îòíîøåíèþ ê òêàíè ùèòîâèäíîé æåëåçû- ìîæåò ñîîòâåòñòâîâàòü àäåíîìå ïàðàùèòîâèäíîé æåëåçû.
Ïàöèåíòêà íàñòðîåíà íà îïåðàòèâíîå ëå÷åíèå(ñâÿçûâàåò ñâîþ äåïðåññèþ,ãàñòðèò,àðòðîç ñ ãèïåðêàëüöèåìèåé). Êîíñóëüòèðîâàííà ýíäîêðèííûì õèðóðãîì - ïðåäëîæåíî îïåðàòèâíîå ëå÷åíèå( äåñêàòü àäåíîìà íèêóäà íå äåíåòñÿ) õîòÿ è íå ñèëüíî íàñòàèâàë. Ïðåäëîæèë ñäåëàòü ñöèíòèãðàôèþ â äâóõ ïðîåêöèÿõ â Ãåðìàíèè. Âàøå ìíåíèå îòïóñêàòü ïàöèåíòêó íà îïåðàöèþ , èëè óãîâîðèòü íà íàáëþäåíèå ( áèñôîñôîíàòû âðîäå ïîêà íå ïîêàçàíû( ãàñòðèò,îñòåîïîðîçà íåò),öåëåñîîáðàçíîñòü ïðîâåäåíèÿ ñöèíòèãðàôèè?
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 24.10.2015, 10:51
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Îáúÿñíèòü ïîêàçàíèÿ ê îïåðàöèè (èëè îòñóòñòâèå òàêîâûõ) è ïðåäóïðåäèòü, ÷òî äåïðåññèÿ, ãàñòðèò è àðòðîç ïîñëå óäàëåíèÿ ïàðàùèòîâèäíîé æåëåçû íèêóäà, ñêîðåå âñåãî, íå äåíóòñÿ - íóæíî. Êîãî-òî íà ÷òî-òî óãîâàðèâàòü - íå óâåðåí.

Êîììåíòàðèè ê ñîîáùåíèþ:
Melnichenko îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 13:07.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.